{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:40:01Z","timestamp":1783381201849,"version":"3.54.6"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.trim.2025.102288","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:51:22Z","timestamp":1758588682000},"page":"102288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effects of intravenous immunoglobulin (IVIG) treatment on BK viremia and BK virus-associated nephropathy (BKVN) in kidney transplant patients: A systematic review"],"prefix":"10.1016","volume":"93","author":[{"given":"Maryam","family":"Hassanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firouzeh","family":"Moeinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.trim.2025.102288_bb0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/kidney disease outcomes quality initiative (NKF\/KDOQI\u2122) conference","volume":"3","author":"Abecassis","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.trim.2025.102288_bb0010","first-page":"216","article-title":"Immunosuppression after renal transplantation. Memo - Magazine of European","volume":"12","author":"Neuwirt","year":"2019","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.trim.2025.102288_bb0015","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.transproceed.2015.05.010","article-title":"BK virus nephropathy in kidney transplantation: an approach proposal and update on risk factors, diagnosis, and treatment","volume":"47","author":"Gonzalez","year":"2015","journal-title":"Transplant. Proc."},{"issue":"7","key":"10.1016\/j.trim.2025.102288_bb0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.trim.2025.102288_bb0025","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","article-title":"Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations","volume":"79","author":"Hirsch","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2025.102288_bb0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcv.2018.10.002","article-title":"Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review","volume":"109","author":"Demey","year":"2018","journal-title":"J. Clin. Virol."},{"issue":"6","key":"10.1016\/j.trim.2025.102288_bb0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/00365599.2012.726643","article-title":"Risk factors and interventional strategies for BK polyomavirus infection after renal transplantation","volume":"46","author":"Steubl","year":"2012","journal-title":"Scand. J. Urol. Nephrol."},{"issue":"2","key":"10.1016\/j.trim.2025.102288_bb0040","first-page":"271","article-title":"BK polyomavirus infection in the renal transplant recipient","volume":"27","author":"Balba","year":"2013","journal-title":"Infect. Dis. Clin."},{"issue":"3","key":"10.1016\/j.trim.2025.102288_bb0045","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ndt\/gfn671","article-title":"Risk factors for polyoma virus nephropathy","volume":"24","author":"Prince","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/j.trim.2025.102288_bb0050","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.transproceed.2015.08.006","article-title":"Risk factors for the development of BK virus nephropathy in renal transplant recipients","volume":"47","author":"Pai","year":"2015","journal-title":"Transplant. Proc."},{"issue":"10","key":"10.1016\/j.trim.2025.102288_bb0055","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1600-6143.2004.00563.x","article-title":"HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients","volume":"4","author":"Awadalla","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.trim.2025.102288_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/v9110327","article-title":"Biology of the BKPyV: an update","volume":"9","author":"Helle","year":"2017","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.trim.2025.102288_bb0065","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/jgv.0.000839","article-title":"ICTV virus taxonomy profile: Polyomaviridae","volume":"98","author":"Moens","year":"2017","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.trim.2025.102288_bb0070","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000003801","article-title":"Polyoma BK virus in kidney transplant recipients: screening, monitoring, and management","volume":"106","author":"Myint","year":"2022","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.trim.2025.102288_bb0075","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/v14081616","article-title":"BK virus nephropathy in kidney transplantation: a state-of-the-art review","volume":"14","author":"Kant","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.trim.2025.102288_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ndt\/gfu023","article-title":"BK virus infection: an update on diagnosis and treatment","volume":"30","author":"Sawinski","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"9","key":"10.1016\/j.trim.2025.102288_bb0085","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2025.102288_bb0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.TP.0000149338.97084.5F","article-title":"Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system","volume":"79","author":"Farasati","year":"2005","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.trim.2025.102288_bb0095","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/TP.0b013e3181daaaf1","article-title":"Polyomavirus BK neutralizing activity in human immunoglobulin preparations","volume":"89","author":"Randhawa","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2025.102288_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/ajt.16233","article-title":"Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients\u2014results from a proof-of-concept study","volume":"21","author":"Benotmane","year":"2021","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2025.102288_bb0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/ijot.ijot_43_22","article-title":"BK virus nephropathy in renal transplantation and the effect of intravenous immunoglobulin: a prospective longitudinal single-center study in South Asia","volume":"17","author":"Ganesh","year":"2023","journal-title":"Indian J. Transplantat."},{"issue":"4","key":"10.1016\/j.trim.2025.102288_bb0110","doi-asserted-by":"crossref","first-page":"E142","DOI":"10.1097\/TXD.0000000000000641","article-title":"Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin","volume":"3","author":"Kable","year":"2017","journal-title":"Transplant. Direct"},{"issue":"1","key":"10.1016\/j.trim.2025.102288_bb0115","first-page":"118","article-title":"Efficacy of mTOR inhibitors and intravenous immunoglobulin for treatment of Polyoma BK nephropathy in kidney transplant recipients: a biopsy-proven study","volume":"22","author":"Karatas","year":"2024","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.trim.2025.102288_bb0120","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/TCRM.S273388","article-title":"Clinical efficacy of intravenous immunoglobulin for BK polyomavirus-associated nephropathy after living kidney transplantation","volume":"16","author":"Matsumura","year":"2020","journal-title":"Ther. Clin. Risk Manag."},{"issue":"4","key":"10.1016\/j.trim.2025.102288_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13300","article-title":"Effects of intravenous immunoglobulin therapy and fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipients","volume":"22","author":"Moon","year":"2020","journal-title":"Transpl. Infect. Dis."},{"issue":"1","key":"10.1016\/j.trim.2025.102288_bb0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.tp.0000181096.14257.c2","article-title":"Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients","volume":"81","author":"Sener","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.trim.2025.102288_bb0135","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.transproceed.2015.01.012","article-title":"Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients","volume":"47","author":"Vu","year":"2015","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.trim.2025.102288_bb0140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/ajt.16233","article-title":"Intravenous immunoglobulins as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients-results from a proof-of-concept study","volume":"21","author":"Benotmane","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2025.102288_bb0145","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/TCRM.S273388","article-title":"Clinical efficacy of intravenous immunoglobulin for BK polyomavirus-associated nephropathy after living kidney transplantation","volume":"16","author":"Matsunnura","year":"2020","journal-title":"Ther. Clin. Risk Manag."},{"issue":"8","key":"10.1016\/j.trim.2025.102288_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00393-19","article-title":"Intravenous immunoglobulin administration significantly increases BKPyV genotype-specific neutralizing antibody titers in kidney transplant recipients","volume":"63","author":"Velay","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.trim.2025.102288_bb0155","series-title":"Clinical Characteristic and Outcomes of BK Virus Infection in Kidney Transplant Recipients Managed using a Systematic Surveillance and Treatment Strategy","author":"Lee","year":"2020"},{"issue":"7","key":"10.1016\/j.trim.2025.102288_bb0160","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ndt\/gfy346","article-title":"Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes","volume":"34","author":"Bischof","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2025.102288_bb0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-6143.2009.02952.x","article-title":"BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results","volume":"10","author":"Hardinger","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.trim.2025.102288_bb0170","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/TP.0b013e3182921995","article-title":"Risk factors for BK virus infection in the era of therapeutic drug monitoring","volume":"95","author":"Borni-Duval","year":"2013","journal-title":"Transplantation"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T21:14:45Z","timestamp":1765055685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327425001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":34,"alternative-id":["S0966327425001169"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2025.102288","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of intravenous immunoglobulin (IVIG) treatment on BK viremia and BK virus-associated nephropathy (BKVN) in kidney transplant patients: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2025.102288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102288"}}